Rosetta Opens Gene Expression Profiling Facility | GenomeWeb

NEW YORK, December 14 - Rosetta Inpharmatics inaugurated Thursday a new gene
expression profiling facility in Bothell, Wash.

At the facility, researchers will use image analysis technology and
molecular biology processes to generate gene expression data for drug and
drug target discovery, the company said.

" Our new facility in Bothell will help us further our efforts in gene
expression research, and will advance our goal to develop solutions that
will accelerate and enhance the drug discovery process," said Rosetta CEO

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.